Company Profiles

driven by the PitchBook Platform

Alexo Therapeutics

Description

Developer of protein-based therapeutics for cancer treatment. The company develops protein-based therapeutics with anticancer antibodies that helps immune system to eradicate cancer from the patients system.

2015

Founded

PRIVATE

Status

Series A

Latest Deal Type

$18M

Latest Deal Amount

$18M

Total Amount Raised

4

Investors

Description

Developer of protein-based therapeutics for cancer treatment. The company develops protein-based therapeutics with anticancer antibodies that helps immune system to eradicate cancer from the patients system.

Website:

www.alexotherapeutics.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Biotechnology

Primary Office

951 Gateway Boulevard Suite 201 South San Francisco, CA 94080United States
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Alexo Therapeutics's full profile, request a free trial.

Alexo Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Alexo Therapeutics Investors (4)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Irish Venture Capital AssociationVenture CapitalMinority000 0000000 0000
Lightstone VenturesVenture CapitalMinority000 0000000 0000
SPARK ScholarsAccelerator/IncubatorMinority000 0000000 0000
venBioVenture CapitalMinority000 0000000 0000
Irish Venture Capital Association Venture Capital
Lightstone Ventures Venture Capital
SPARK Scholars Accelerator/Incubator
venBio Venture Capital

Alexo Therapeutics Executive Team (7)

NameTitleBoard
Seat
Contact
Info
Jaume Pons Ph.DChief Executive Officer, Board Member, President and Co-Founder
John BorgesonChief Financial Officer
Hank SternVice President, Chemistry, Manufacturing, and Controls
Hong Wan Ph.DVice President, Early Development and Translational Medicine
Michael ChangVice President, Operations
Jaume Pons Ph.D Chief Executive Officer, Board Member, President and Co-Founder
John Borgeson Chief Financial Officer
Hank Stern Vice President, Chemistry, Manufacturing, and Controls
Hong Wan Ph.D Vice President, Early Development and Translational Medicine
Michael Chang Vice President, Operations

Alexo Therapeutics Board Members (5)

NameRepresentingRoleSinceContact
Info
Corey GoodmanAlexo TherapeuticsChairman of the Board000 0000
Jason LettmanAlexo TherapeuticsBoard Member000 0000
Jaume Pons Ph.DAlexo TherapeuticsChief Executive Officer, Board Member, President and Co-Founder000 0000
K. GarciaAlexo TherapeuticsBoard Observer & Board Member000 0000
Laura DemingSelfBoard Observer & Board Member000 0000
Corey Goodman Chairman of the Board Alexo Therapeutics
Jason Lettman Board Member Alexo Therapeutics
Jaume Pons Ph.D Chief Executive Officer, Board Member, President and Co-Founder Alexo Therapeutics
K. Garcia Board Observer & Board Member Alexo Therapeutics
Laura Deming Board Observer & Board Member Self
Request full access to PitchBook